Stemtech Corporation
STEK · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 2.7% | 7.9% | 5.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 73.8% | 79.6% | 74.5% | 76.3% |
| EBITDA | -$0 | $0 | -$0 | $0 |
| % Margin | -35.2% | 1% | -87.6% | 35.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -74.6% | -110.3% | -189.3% | -353.7% |
| EPS Diluted | -0.032 | -0.065 | -0.19 | -0.41 |
| % Growth | 51.2% | 65.7% | 53.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |